… Miller,31 Lisa G. Rider,31 and the International Myositis Classification Criteria Project
Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study …

Objective In polymyositis and dermatomyositis (DM), identified autoantibodies occur in <50%
of adult patients and in a smaller proportion of children. This study was undertaken as part …

Monozygotic (MZ) twins are partially concordant for most complex diseases, including
autoimmune disorders. Whereas phenotypic concordance can be used to study heritability, …

Objective To assess the safety and efficacy of rituximab in a randomized, double‐blind,
placebo‐phase trial in adult and pediatric myositis patients. Methods Adults with refractory …

Juvenile dermatomyositis, the most common inflammatory myopathy of childhood, is a rare
systemic autoimmune vasculopathy that is characterised by weakness in proximal muscles …

The lack of standardized criteria for quantitative measurement of therapeutic response in
clinical trials poses a major obstacle for the development of new agents in chronic graft-versus-…

… Address correspondence to Lisa G. Rider, MD, Environmental Autoimmunity Group, Program
of Clinical Research, National Institute of Environmental Health Sciences, NIH, CRC 4-2352…

… Aggarwal and Rider contributed equally to this work. Drs. Miller and Vencovsky contributed
… Aggarwal and Rider had full access to all of the data in the study and take responsibility for …

Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an …

The juvenile idiopathic inflammatory myopathies (JIIM) are systemic autoimmune diseases
characterized by skeletal muscle weakness, characteristic rashes, and other systemic features…